Bacterial Diseases
Bacterial Diseases(细菌性疾病)
Bacterial Diseases 相关产品(602)
- GC43222Cefazolin-13C2,15NCAS: 2101505-58-0纯度: >95.00%
An internal standard for the quantification of cefazolin
- GC43390DeacetylravidomycinCAS: 88580-27-2纯度: >95.00%
A microbial metabolite with light-dependent antibiotic and anticancer activities
- GC43418Desethylene Ciprofloxacin (hydrochloride)CAS: 528851-31-2纯度: >98.00%
A major metabolite and degradation product of ciprofloxacin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43142 | Cardanol diene | 51546-63-5 | >95.00% | |
A tyrosinase inhibitor | ||||
| GC43143 | Cardanol triene | 79353-39-2 | >95.00% | |
A tyrosinase inhibitor | ||||
| GC43197 | CAY10711 | 1666171-29-4 | >95.00% | |
A substituted diamine antibiotic | ||||
| GC43222 | Cefazolin-13C2,15N | 2101505-58-0 | >95.00% | |
An internal standard for the quantification of cefazolin | ||||
| GC43237 | Chevalone C | 1318025-77-2 | >95.00% | |
A fungal metabolite | ||||
| GC43240 | Chloramphenicol Acetate | 10318-16-8 | >97.00% | |
An acetylated version of chloramphenicol | ||||
| GC43242 | Chloramphenicol Succinate | 3544-94-3 | >99.00% | |
A prodrug form of chloramphenicol | ||||
| GC43244 | Chlorin e6 | 19660-77-6 | >90.00% | |
Chlorin e6(Ce6) 是第二代光敏剂。 | ||||
| GC43274 | Citromycetin | 478-60-4 | >95.00% | |
A fungal metabolite | ||||
| GC43278 | Clindamycin Sulfoxide | 22431-46-5 | >90.00% | |
An active metabolite of clindamycin | ||||
| GC43298 | Colistin | 1066-17-7 | >95.00% | |
An antibiotic | ||||
| GC43314 | Corynecin I | 4423-58-9 | >99.00% | |
A chloramphenicol-like antibiotic | ||||
| GC43342 | Cyclo(L-Leu-L-Pro) | 2873-36-1 | >99.00% | |
A diketopiperazine metabolite | ||||
| GC43390 | Deacetylravidomycin | 88580-27-2 | >95.00% | |
A microbial metabolite with light-dependent antibiotic and anticancer activities | ||||
| GC43394 | Decatromicin B | 235097-64-0 | >95.00% | |
A bacterial metabolite | ||||
| GC43395 | Deethylindanomycin | 106803-22-9 | >95.00% | |
A polyether antibiotic | ||||
| GC43396 | Defensin HNP-1 (human) (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC43397 | Defensin HNP-2 (human) (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC43398 | Defensin HNP-3 (human) (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC43408 | Deoxycholic Acid (sodium salt hydrate) | 145224-92-6 | >95.00% | |
A secondary bile acid | ||||
| GC43418 | Desethylene Ciprofloxacin (hydrochloride) | 528851-31-2 | >98.00% | |
A major metabolite and degradation product of ciprofloxacin | ||||
| GC43424 | Desotamide | 194660-14-5 | >95.00% | |
An antibiotic | ||||
| GC43467 | Dimethyldioctadecylammonium (bromide) | 3700-67-2 | >95.00% | |
A cationic amphipathic lipid | ||||
| GC43572 | Drimentine A | 204398-90-3 | >98.00% | |
An antibiotic | ||||